CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

May 01, 12:00 PM

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to give details on Precision Oncology, tumor & drug testing, and growing via targeted therapies.

NASDAQ: AIPT # formerly Skyline Medical: SKLN # FDA-approved STREAMWAY® System # Helomics Corporation # automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovarian cancer # patented # Precision Oncology # Tumor treatments # waste fluid management